Stock Taper
Latest 13F filing data - Q2 2026
| STOCK | TICKER | SHARES HELD▲ ▼ | VALUE▲ ▼ |
|---|---|---|---|
Erasca, Inc. | ERAS | 12.15M | $222.59M |
Ocular Therapeutix, Inc. | OCUL | 5.3M | $52.05M |
Olema Pharmaceuticals, Inc. | OLMA | 3.21M | $40.14M |
Design Therapeutics, Inc. | DSGN | 3M | $43.41M |
IDEAYA Biosciences, Inc. | IDYA | 3M | $111.81M |
Tango Therapeutics, Inc. | TNGX | 2.85M | $89.09M |
MoonLake Immunotherapeutics | MLTX | 2.67M | $52.08M |
Dyne Therapeutics, Inc. | DYN | 2.55M | $56.64M |
Replimune Group, Inc. | REPL | 2.5M | $27.68M |
COMPASS Pathways plc | CMPS | 2.25M | $31.84M |
Editas Medicine, Inc. | EDIT | 2.22M | $7.2M |
Vera Therapeutics, Inc. | VERA | 2.2M | $94.4M |
Celldex Therapeutics, Inc. | CLDX | 2.1M | $78.14M |
Trevi Therapeutics, Inc. | TRVI | 1.88M | $35.06M |
Summit Therapeutics Inc. | SMMT | 1.35M | $19.67M |
Jade Biosciences, Inc. | JBIO | 1.13M | $25M |
Mineralys Therapeutics, Inc. | MLYS | 1.05M | $28.33M |
Abivax S.A. | ABVX | 1.02M | $136.46M |
BioNTech SE | BNTX | 1.01M | $94.45M |
ArriVent BioPharma, Inc. | AVBP | 1M | $34.74M |